JESSICA GALVEZ: Open Payments
NPI 1952976052 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 155 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $969 · 2025 $2,587
Food & beverage: $2,580Education: $7
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 43 | $680 |
| UCB, Inc. | 27 | $453 |
| Mallinckrodt Hospital Products Inc. | 20 | $299 |
| ANI Pharmaceuticals, Inc. | 20 | $292 |
| ABBVIE INC. | 16 | $282 |
| AstraZeneca Pharmaceuticals LP | 10 | $222 |
| GlaxoSmithKline, LLC. | 6 | $103 |
| Aurinia Pharma U.S., Inc. | 5 | $94 |
| Alexion Pharmaceuticals, Inc. | 3 | $44 |
| Organon LLC | 2 | $40 |
Products named: Bimzelx, ACTHAR, PURIFIED CORTROPHIN GEL, KRYSTEXXA, RINVOQ, SAPHNELO, TAVNEOS, BENLYSTA.
Industry payments across TX — which companies pay providers there.
